jolly19 Feb 2016 17:23
from a TA view i think you have a good entry, yesterdays SP hit and bounced off long term trend line (going back from 2009) and today had a nice uplift from this bounce which could indicate that the trend line held up as support. if we fell below the double bottom around 54p then would be bad news and no long on yearly bull trend and could see a drop down to 30p
RSI was oversold yesterday so due a bounce, which could of been yesterday/ todays play. so in my eyes you have a nice entry. i would set a limit of 50p. sell up and rebuy on 30p (if and big if it does it)
i do also have concerns regarding competition dibs but what puts AGL separate from the competition is that AGL is the only device capable of capturing cells for harvesting which could be AGL key in the market and will soon (hopefully soon yet it has been years) become the first in the world to have FDA approval for such a device, understand there is competition but AGL could be a few years infront of the competitors regarding the whole FDA approval process and clinal trials etc. others will take years to become a big player. im hoping FDA is within the near future and a possible buy out from one of the big phamas will take place.
the longer FDA takes the more people will loose trust in BOD and get bored so will move money elsewhere.
im still being AGL and the BOD which do not come across shady or trying to be uber bullish, theyre letting the reviews speak for parsortix.
been in a few years and will continue to hold as like the company. have already derisked along the way when AGL had a good year in 2013 but a bit wary in adding until more concrete news follows regarding progess on FDA approval.